精神分裂症作为21世纪精神卫生工作的重点,同时作为临床上常见的较为严重的精神障碍之一,一直是临床重点管理及防控的工作内容。精神分裂症的治疗也作为各项研究关注的重点。神经递质以及脑源性神经营养因子的异常作为精神分裂症发病机...精神分裂症作为21世纪精神卫生工作的重点,同时作为临床上常见的较为严重的精神障碍之一,一直是临床重点管理及防控的工作内容。精神分裂症的治疗也作为各项研究关注的重点。神经递质以及脑源性神经营养因子的异常作为精神分裂症发病机制中重要环节也常被人关注。本文综述了无抽搐电休克(modified electroconvulsive therapy, MECT)联合二代抗精神病药物治疗精神分裂症的疗效及其对神经递质、脑源性神经营养因子(BDNF)的影响等,从多个方面探讨并总结目前精神分裂症治疗的进展。As the focus of mental health work in the 21st century, and as one of the more serious mental disorders commonly seen in clinical practice, schizophrenia has always been the focus of clinical management, prevention and control. The treatment of schizophrenia has also been the focus of various studies. Abnormalities in neurotransmitters and brain-derived neurotrophic factors are also often considered an important part of the pathogenesis of schizophrenia. This article reviews the efficacy of modified electroconvulsive therapy (MECT) combined with second-generation antipsychotic drugs in the treatment of schizophrenia and its effects on neurotransmitters and brain-derived neurotrophic factor (BDNF). It explores and summarizes the current progress in the treatment of schizophrenia from multiple perspectives.展开更多
文摘精神分裂症作为21世纪精神卫生工作的重点,同时作为临床上常见的较为严重的精神障碍之一,一直是临床重点管理及防控的工作内容。精神分裂症的治疗也作为各项研究关注的重点。神经递质以及脑源性神经营养因子的异常作为精神分裂症发病机制中重要环节也常被人关注。本文综述了无抽搐电休克(modified electroconvulsive therapy, MECT)联合二代抗精神病药物治疗精神分裂症的疗效及其对神经递质、脑源性神经营养因子(BDNF)的影响等,从多个方面探讨并总结目前精神分裂症治疗的进展。As the focus of mental health work in the 21st century, and as one of the more serious mental disorders commonly seen in clinical practice, schizophrenia has always been the focus of clinical management, prevention and control. The treatment of schizophrenia has also been the focus of various studies. Abnormalities in neurotransmitters and brain-derived neurotrophic factors are also often considered an important part of the pathogenesis of schizophrenia. This article reviews the efficacy of modified electroconvulsive therapy (MECT) combined with second-generation antipsychotic drugs in the treatment of schizophrenia and its effects on neurotransmitters and brain-derived neurotrophic factor (BDNF). It explores and summarizes the current progress in the treatment of schizophrenia from multiple perspectives.
